TOKYO -- Fujifilm Holdings announced Tuesday the start of a clinical trial for its flu-fighting drug Avigan to treat COVID-19, in which it will be administered to about 100 patients in Japanese hospitals to gauge safety and efficacy.
Some doctors in Japan are already using the medication to treat coronavirus patients for test purposes, but company-led clinical trials are a must to gain its approval for wide distribution.
